RC
Rohit Chauhan
About Rohit Chauhan
Rohit Chauhan has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Morecare Pharmatec Private Limited. Formerly with 4 companies, such as Brotkin Lifesciences Private Limited and Alexcure Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Morecare Pharmatec Private Limited
U24290HR2020PTC089103
|
Director | 20 Aug 2024 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Brotkin Lifesciences Private Limited
U51909CH2022PTC044551
|
Director | 05 Aug 2022 | 2022 | Active |
Alexcure Lifesciences Private Limited
U24299CH2020PTC043215
|
Director | 12 Sep 2020 | 2020 | Active |
Zoydec Pharmaceuticals Private Limited
U24230CH2020PTC043424
|
Director | 31 Dec 2020 | 2020 | Active |
Chemross Lifesciences Private Limited
U24304CH2019PTC042737
|
Director | 17 Oct 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Chauhan
Rohit Chauhan has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Morecare Pharmatec Private Limited. Formerly with 4 companies, such as Brotkin Lifesciences Private Limited and Alexcure Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.
Rohit Chauhan is associated with 1 company as Director.
Rohit Chauhan has expertise in General Business.
Rohit Chauhan has 6 years in corporate governance.